A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor

Treatment with TNFα inhibitors increases risk of reactivating a latent tuberculosis\infection (LTBI). Therefore screening, prior to therapy with TNFα inhibitors, has been recommended, even in low-endemic areas such as well-developed Western Europe countries. We evaluated interferon-gamma release ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwakernaak, Arjan J., Houtman, Pieternella M., Weel, Jan F. L., Spoorenberg, Johanna P. L., Jansen, Tim L. T. A.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062765/
https://www.ncbi.nlm.nih.gov/pubmed/20737179
http://dx.doi.org/10.1007/s10067-010-1550-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062765/
https://www.ncbi.nlm.nih.gov/pubmed/20737179
http://dx.doi.org/10.1007/s10067-010-1550-z

Ejemplares similares